CareAcross

CareAcross

Posted over 2 years ago

New treatment for certain metastatic breast cancers approved

The US FDA approved a new treatment for hormone-receptor positive, HER2-negative advanced or metastatic breast cancer that has progressed after endocrine therapy.

Read full article

CareAcross

Posted over 2 years ago

Some breast cancer patients may have shorter radiotherapy course

A study showed that a higher-dose, shorter form of radiation is safe, effective, and no more damaging to the breast tissue or skin of breast cancer patients under age 50 than it is in older patients.

Read full article

CareAcross

Posted over 2 years ago

Broader use for fulvestrant approved in some breast cancer types

Fulvestrant has been approved by the FDA for broader use in hormone-receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer.

Read full article

CareAcross

Posted over 2 years ago

Genetic tests not always done when recommended

Fewer women with history of breast and ovarian cancer take a recommended genetic test. This may increase their risk for additional cancers in the future.

Read full article

CareAcross

Posted about 3 years ago

Less breast cancer radiation has better cosmetic outcomes, say 65+ patients

Breast cancer patients aged 65+ reported being more satisfied long term with the cosmetic outcomes of less radiation. However, this should be balanced with a slightly higher recurrence risk.

Read full article

CareAcross

Posted about 3 years ago

Combination treatment for HR positive, HER2 positive breast cancer improves outcomes

Adding pertuzumab to a standard regimen for hormone receptor-positive, HER2-positive, locally advanced or metastatic breast cancer improved progression-free survival in a clinical trial.

Read full article

CareAcross

Posted about 3 years ago

A system to cool the scalp may help prevent hair loss for breast cancer patients

In a clinical trial, women diagnosed with stage 1 or 2 breast cancer used a scalp-cooling system while undergoing chemotherapy. The results show that it helped them prevent hair loss.

Read full article

CareAcross

Posted about 3 years ago

Improved response to treatment against breast cancer with BRCA mutation

Adding veliparib to carboplatin and paclitaxel chemotherapy improved the overall response rate among patients with locally recurrent or metastatic breast cancer with BRCA1 or BRCA2 mutations.

Read full article

CareAcross

Posted over 2 years ago

Grilled meat linked to higher risks for breast cancer patients

Recent findings show that higher consumption of grilled, barbequed, and smoked meat may increase the mortality risk among breast cancer survivors.

Read full article

CareAcross

Posted about 3 years ago

Combining breast cancer treatments more than double progression free survival

Adding everolimus to fulvestrant more than doubled progression-free survival for women with metastatic hormone receptor (HR)-positive, HER2-negative breast cancer resistant to aromatase inhibitor therapy.

Read full article

CareAcross

Posted about 3 years ago

Combination therapy against HR-positive, HER2-negative advanced breast cancer

Buparlisib, in combination with fulvestrant endocrine therapy, improved outcomes for patients with hormone (HR)-positive advanced breast cancer after treatment with everolimus plus exemestane.

Read full article

CareAcross

Posted about 3 years ago

Radiation therapy before breast reconstruction may affect quality of life

Many breast cancer patients will consider breast reconstruction after mastectomy. Radiation therapy can alter the tissue around the breast, impacting reconstruction efforts.

Read full article

CareAcross

Posted about 3 years ago

Combination therapy for metastatic breast cancer shows improved survival

Progression-free survival doubled in patients with aromatase inhibitor-resistant metastatic breast cancer treated with everolimus plus fulvestrant vs fulvestrant alone.

Read full article

CareAcross

Posted about 3 years ago

Could weight loss help reduce risk of breast cancer recurrence?

Emerging research seems to indicate that women who had breast cancer and maintain a normal weight have lower risk of the cancer coming back.

Read full article

CareAcross

Posted about 3 years ago

New combination therapy for breast cancer one step closer to approval

Adding palbociclib to letrozole for the treatment of estrogen receptor positive (ER+), HER2-negative (HER2-) advanced breast cancer increased progression-free survival from 14.5 to over 25 months.

Read full article

CareAcross

Posted about 3 years ago

Women with history of depression may have worse outcomes in breast cancer

Women who have a history of depression may have worse survival outcomes, compared to patients without past mental health challenges. This is based on Danish research.

Read full article

CareAcross

Posted about 3 years ago

Higher vitamin D levels may be linked to better breast cancer outcomes

Breast cancer patients with high vitamin D levels in the blood may have less dangerous tumors and better outcomes. This is according to research within an ongoing study.

Read full article

CareAcross

Posted about 3 years ago

New breast cancer drug approved by the European Commission

Palbociclib is now approved in Europe for the treatment of women with hormone receptor-positive, HER2-negative (HR+/HER2-), locally advanced or metastatic breast cancer.

Read full article

CareAcross

Posted about 3 years ago

Benefits of breast reconstruction after mastectomy do not change much with age

Older women enjoy the same benefits from breast reconstruction following mastectomy for breast cancer as younger women without much higher risk for complications.

Read full article

CareAcross

Posted about 3 years ago

Precision medicine contributes in chemotherapy decisions

Precision medicine test in cancer care helps patients and doctors decide if chemotherapy is the proper treatment and what side effects will occur.

Read full article

CareAcross

Posted over 3 years ago

Sunitinib increases disease-free survival in renal cell carcinoma

Sunitinib can increase disease-free survival as adjuvant treatment for renal cell carcinoma after nephrectomy.

Read full article

CareAcross

Posted over 3 years ago

Ribociclib increases progression-free survival in breast cancer

Ribociclib (CDK4/6 inhibitor) combined with letrozole improves by 44% the progression-free survival in postmenopausal women with hormone receptor positive advanced breast cancer.

Read full article

CareAcross

Posted over 3 years ago

Niraparib improves outcomes in patients with ovarian cancer

The PARP inhibitor niraparib improves primary and secondary endpoints in platinum-sensitive recurrent ovarian cancer. Survival was significantly improved.

Read full article

CareAcross

Posted over 3 years ago

A specific estrogen receptor prolongs survival in breast cancer

Fulvestrant increases progression-free survival (PFS) in hormone receptor positive (ER+) advanced breast cancer patients.

Read full article

CareAcross

Posted over 3 years ago

Innovative alternative to mastectomy in recurrent breast cancer

Treating recurrent breast cancer with a 2nd lumpectomy and partial breast irradiation brings better results compared to conventional breast surgery.

Read full article

CareAcross

Posted over 3 years ago

Breast reconstruction right after mastectomy improves psychology

Immediate breast reconstruction (IBR) after mastectomy causes fewer breast cancer psychological side-effects, compared to delayed breast reconstruction (DBR).

Read full article

CareAcross

Posted over 3 years ago

Additional radiation decreases recurrence rate of ductal carcinoma

A supplemental "boost" of radiation may reduce breast cancer recurrence in Ductal Carcinoma in Situ (DCIS) patients.

Read full article

CareAcross

Posted over 3 years ago

Recommendations on post-mastectomy RT in breast cancer

An expert panel issued recommendations on post-mastectomy radiation therapy for breast cancer patients, calling for careful counseling and clinical judgement.

Read full article

CareAcross

Posted over 3 years ago

Apixaban shows promise for atrial fibrillation cancer patients

Cancer patients treated with apixaban saw a 70% reduction in the composite endpoint of stroke, new findings show.

Read full article

CareAcross

Posted over 3 years ago

Unravelling the chemo brain: how long does it last?

Half of female breast cancer survivors may suffer from chemo brain, a genuine consequence of chemotherapy. Study tries to find how long it is likely to last.

Read full article

CareAcross

Posted over 3 years ago

How obesity & smoking influence cardiotoxicity in breast cancer

Obesity and smoking were associated with higher risk of developing cardiotoxicity after treatment in breast cancer patients, clinical studies reveal.

Read full article

CareAcross

Posted over 3 years ago

Olanzapine prevented chemotherapy-induced nausea

Patients undergoing chemotherapy experienced no nausea or vomiting after including olanzapine to their prophylactic drug combination, a phase 3 study reveals.

Read full article

CareAcross

Posted over 3 years ago

Why do breast cancer survivors suffer from chronic pain?

A new analysis shows that cutting of sensory nerves during breast cancer surgery is connected with post-surgical chronic pain.

Read full article

CareAcross

Posted over 3 years ago

Fewer memory problems for breast cancer survivors who exercise

Physical activity improved subjective memory in breast cancer survivors, alleviating stress, a new study reports.

Read full article

CareAcross

Posted over 3 years ago

A diagnosis of high cholesterol led to increased cancer survival

A diagnosis of high cholesterol led to reduced mortality and improved survival in lung, breast, prostate and bowel cancer, a new researches reveals.

Read full article

CareAcross

Posted over 3 years ago

Acupressure helps breast cancer survivors deal with fatigue

Breast cancer survivors who did acupressure over six weeks reduced fatigue, the most common long-term effects of breast cancer treatment.

Read full article

CareAcross

Posted over 3 years ago

Smoking reduced the benefit of common breast cancer treatment

Breast cancer patients treated with aromatase inhibitors who continued smoking had a three times higher risk of recurrence of breast cancer, a study shows.

Read full article

CareAcross

Posted over 3 years ago

Treatment combination prolonged life in prostate cancer

Adding radiotherapy to androgen deprivation therapy in the treatment of metastatic prostate cancer patients prolonged survival more, an analysis reveals.

Read full article

CareAcross

Posted over 3 years ago

Is shorter radiation better for early breast cancer patients?

Treating early breast cancer patients with a shorter course of whole breast radiation induced the same outcomes as the longer course, a study reveals.

Read full article

CareAcross

Posted over 3 years ago

Arimidex improved quality of life in endometrial cancer patients

Arimidex induced a clinical benefit for recurrent hormone receptor-positive endometrial cancer patients, as it improved their quality of life, a study finds.

Read full article

CareAcross

Posted over 3 years ago

Chemotherapy combo prolongs survival in pancreatic cancer

Treating pancreatic cancer patients with oral chemotherapy drug capecitabine with gemcitabine prolonged their survival without increasing toxicity.

Read full article

CareAcross

Posted over 3 years ago

Breast cancer: lower risk of recurrence with hormone therapy

Postmenopausal breast cancer patients had a 34% lower risk of recurrence after receiving hormone therapy letrozole from 5 to 10 years, a new study shows.

Read full article

CareAcross

Posted over 3 years ago

Tackling chemo side effects with personalized exercise program

Exercise reduced symptoms of neuropathy due to chemotherapy in cancer patients, investigators report.

Read full article

CareAcross

Posted over 3 years ago

Ovarian Cancer: extended survival with hormonal maintenance therapy

Treating patients of low-grade serous carcinoma (LGSC) of the ovary or peritoneum with hormonal maintenance therapy improved progression-free survival.

Read full article

CareAcross

Posted over 3 years ago

Early positive results for Novartis breast cancer drug

Novartis halted early the clinical trial of the experimental breast cancer drug LEE011 in combination with letrozole due to positive results, the company announced.

Read full article

CareAcross

Posted over 3 years ago

Avastin combo improves survival in advanced breast cancer

A breast cancer combination treatment improved progression-free survival but not other outcomes, a new phase 3 study showed.

Read full article

CareAcross

Posted over 3 years ago

Soft tissues sarcomas: Europe gets one step closer to treatment

EU regulators have approved eribulin for the treatment of adult patients with unresectable liposarcomas.

Read full article

CareAcross

Posted over 3 years ago

Positive results from Keytruda in triple-negative breast cancer

Pembrolizumab (Keytruda) induced promising clinical activity in heavily pretreated patients with advanced triple-negative breast cancer.

Read full article

CareAcross

Posted over 3 years ago

Breast cancer surgery: does the patient’s age affect the outcomes?

The patient’s age and the type of breast cancer surgery affects the outcomes in breast cancer patients, a new Danish study reveals.

Read full article

CareAcross

Posted over 3 years ago

Breast conserving therapy Vs mastectomy in early breast cancer

Breast conserving therapy was associated with a higher risk of metastasis compared to mastectomy in early breast cancer patients, younger than 45 years old.

Read full article

CareAcross

Posted over 3 years ago

Newer hormone therapy doesn’t increase heart risk in breast cancer

Breast cancer patients treated with aromatase inhibitors, hormone-therapy drugs, were not in increased risk of fatal cardiovascular events, new study reports.

Read full article

CareAcross

Posted over 3 years ago

Heart surveillance: necessary after herceptin in breast cancer

Monitoring for heart damage should be regular in breast cancer patients undergoing treatment with trastuzumab-containing regimens, a new study says.

Read full article

CareAcross

Posted over 3 years ago

Low fat diet increased survival in breast cancer patients

Following a low fat diet increased breast cancer overall survival from diagnosis in postmenopausal women, a new study finds.

Read full article

CareAcross

Posted over 3 years ago

Is delayed radiation harmful for women with breast abnormality?

Women treated for ductal carcinoma in situ (DCIS) receiving delayed radiation treatment were at risk developing malignant breast tumors, a new study shows.

Read full article

CareAcross

Posted almost 4 years ago

Aromasin demonstrates efficacy against breast cancer recurrence

Exemestane (Aromasin) plus ovarian function suppression (OFS) proved to be more beneficial for breast cancer patients than tamoxifen with or without OFS.

Read full article

CareAcross

Posted almost 4 years ago

Healthy breast removal won’t increase survival in breast cancer

Removing the second, healthy breast rose from 4% in breast cancer patients in 2002 to nearly 13% in 2012. However, this removal will not reduce the risk of dying.

Read full article

CareAcross

Posted almost 4 years ago

Genomic test helps early breast cancer patients avoid chemo

Genomic testing can be used to help accurately select early breast cancer patients who can safely be spared chemotherapy, a new study shows.

Read full article

CareAcross

Posted almost 4 years ago

Neurofeedback against chemotherapy-induced neuropathy

Cancer patients experiencing chemotherapy-induced neuropathy after chemotherapy improved their quality of life and reduced pain using neurofeedback.

Read full article

CareAcross

Posted almost 4 years ago

Breast cancer tumors shrunk with lapatinib and trastuzumab combo

Tumors of breast cancer patients either shrunk or disappeared after treatment with a combination of lapatinib and trastuzumab.

Read full article

CareAcross

Posted almost 4 years ago

Linking early stage breast cancer and high white blood cell ratio

A retrospective study reports that a high white blood cell ratio in early stage breast cancer patients is linked to an increased risk of disease recurrence.

Read full article

CareAcross

Posted almost 4 years ago

Less breast cancer side effects with partial radiotherapy

Focusing postoperative radiotherapy around tumor containing cells has fewer long-term side effects and low recurrence rate in breast cancer patients.

Read full article

CareAcross

Posted almost 4 years ago

Improved survival in breast cancer with 'dose-dense' chemo

A meta-analysis revealed that dose-dense adjuvant chemotherapy significantly improved overall survival in premenopausal women with breast cancer.

Read full article

CareAcross

Posted almost 4 years ago

Double mastectomy: not the best option for breast cancer patients

A new study reports that undergoing double mastectomy did not improve the quality of life of breast cancer patients.

Read full article

CareAcross

Posted almost 4 years ago

The importance of mapping a patient’s family health history

Mapping a patient’s family health history helped identify at-risk patients leading them to timely screening while saving others from unnecessary monitoring tests.

Read full article

CareAcross

Posted almost 4 years ago

Childhood Hodgkin's lymphoma survivors are at risk of breast cancer

Childhood Hodgkin's lymphoma survivors are at risk of breast cancer say researchers, adding that early screening reduces risk of breast cancer death.

Read full article

CareAcross

Posted almost 4 years ago

Everolimus gets FDA approval for another indication

Everolimus got approved by the FDA for the treatment of inoperable, locally advanced or metastatic neuroendocrine tumors of gastrointestinal or lung origin.

Read full article

CareAcross

Posted almost 4 years ago

Palbociclib gets early FDA approval for breast cancer

US regulators approved earlier than scheduled palbociclib in combination with fulvestrant for the treatment of some cases of breast cancer.

Read full article

CareAcross

Posted almost 4 years ago

Interrupting radiation therapy may lead to cancer recurrence

A new study reveals that interrupting radiation therapy during cancer treatment may lead to cancer recurrence, especially for head and neck cancers.

Read full article

CareAcross

Posted almost 4 years ago

Risk link identified between breast and thyroid cancer survivors

Breast or thyroid cancer survivors are more likely to develop the other type later in life compared to women with no breast or thyroid cancer history.

Read full article

CareAcross

Posted almost 4 years ago

Are adult cancer survivors at risk of heart disease?

Adult cancer survivors are at increased risk of cardiovascular disease, a new U.S. study finds. Moreover, survivors of certain cancers face a higher risk.

Read full article

CareAcross

Posted almost 4 years ago

Is heart testing necessary for cancer patients on chemotherapy?

Cancer patients undergoing chemotherapy should be made aware of the increased risk of heart problems related to chemotherapy’s toxic effects.

Read full article

CareAcross

Posted almost 4 years ago

Breast reconstruction with fat injection: safe in breast cancer

Breast reconstruction with fat injection proved to be safe for women with recurrent breast cancer, according to a new study.

Read full article

CareAcross

Posted almost 4 years ago

FDA approves breast cancer drug Halaven for liposarcoma

Eisai’s breast cancer drug eribulin mesylate (Halaven) received FDA’s approval to treat patients with liposarcoma.

Read full article

CareAcross

Posted almost 4 years ago

Why should breast cancer patients quit smoking?

One large study assessing breast cancer survivors’ smoking habits both before and after diagnosis reports that quitting smoking after diagnosis lowers risk of death.

Read full article

CareAcross

Posted almost 4 years ago

Breast cancer may come back even after 24 years

A new analysis reveals that ER-positive (ER+) breast cancer may return even after more than 24 years of follow-up.

Read full article

CareAcross

Posted about 4 years ago

Treatment changes to childhood cancer extend survivors lives

Changes in pediatric cancer therapy led to decreased death rate and treatment-related death rate in childhood cancer survivors, evidence shows.

Read full article

CareAcross

Posted about 4 years ago

Chemotherapy-induced peripheral neuropathy: a common side effect

Chemotherapy-induced peripheral neuropathy is a common side effect for women cancer survivors, a new study reveals.

Read full article

CareAcross

Posted about 4 years ago

Improving a cancer patient’s quality of life with exercise

Starting adapted fitness routines during treatment rather than waiting until afterward proved to be more beneficial for cancer patients, a new analysis reveals.

Read full article

CareAcross

Posted about 4 years ago

The financial burden of surviving cancer

Studying medical expenditures and productivity losses in cancer patients, scientists report that the financial burden is influenced by age and cancer site.

Read full article

CareAcross

Posted about 4 years ago

Preserving ovarian function in breast cancer patients

Breast cancer patients who achieved ovarian suppression with the hormonal drug triptorelin had more chances to recover ovarian function, a new study shows.

Read full article

CareAcross

Posted about 4 years ago

Working while fighting cancer

Patients with advanced cancer choose to continue working after their diagnosis. However, many aspects of the disease prevent them from doing so.

Read full article

CareAcross

Posted about 4 years ago

Effective method to detect breast cancer-related lymphedema

Counting the symptoms of breast cancer-related lymphedema appeared to be diagnostically relevant and a cost-effective initial screening tool for lymphedema.

Read full article

CareAcross

Posted about 4 years ago

“Poor” quality of life in thyroid cancer survivors

In a recent study assessing the physical, psychological, social and spiritual wellbeing of thyroid cancer survivors, a “poor” quality of life was reported.

Read full article

CareAcross

Posted about 4 years ago

Comparing two treatments for common type of breast cancer

Postmenopausal women with ductal carcinoma in-situ treated with anastrozole saw no difference in outcome compared to treatment with tamoxifen.

Read full article

CareAcross

Posted about 4 years ago

Breast cancer survival linked to delayed treatment

Delaying treatment and chemotherapy influences the survival rates of breast cancer patients, two large U.S. studies suggest.

Read full article

CareAcross

Posted about 4 years ago

Is breast-conserving therapy better for breast cancer patients?

Early-stage breast cancer patients who received breast-conserving surgery plus radiation therapy instead of mastectomy lived longer, scientists report.

Read full article

CareAcross

Posted about 4 years ago

Adjuvant chemotherapy: not effective for all breast cancer patients

Premenopausal women whose invasive breast cancers were of the luminal A subtype did not benefit from a treatment with adjuvant chemotherapy.

Read full article

CareAcross

Posted about 4 years ago

Anxious about getting a genetic cancer screening?

Counseling before and after a genetic cancer screening helped BRCA 1/2-negative patients make informed decisions and deal with anxiety, a new research reveals.

Read full article

CareAcross

Posted about 4 years ago

Denosumab reduces breast cancer relapse rate

The monoclonal antibody (denosumab) given as adjuvant therapy with aromatase inhibitors reduced disease relapse rate in breast cancer patients.

Read full article

CareAcross

Posted about 4 years ago

Improved outcomes for breast cancer patients with capecitabine

Breast cancer patients with residual disease after pre-surgery chemotherapy lived longer after being treated with the chemotherapy agent capecitabine.

Read full article

CareAcross

Posted about 4 years ago

Increased survival for patients with triple-negative breast cancer

Patients with triple-negative breast cancer who had no residual invasive cancer detected after pre-surgery chemotherapy lived longer, scientists discovered.

Read full article

CareAcross

Posted about 4 years ago

Combing palbociclib with paclitaxel against advanced breast cancer

The combination of the palbociclib with paclitaxel (Taxol) induced positive patient outcomes when administered to estrogen-receptor positive breast cancer patients.

Read full article

CareAcross

Posted about 4 years ago

Linking breast cancer treatment and leukemia

Breast cancer survivors at risk of developing leukemia due to chemotherapy and/or radiation share certain characteristics, a new analysis shows.

Read full article

CareAcross

Posted about 4 years ago

Depression: a survival predictor in head and neck cancer

A new study reveals that depression has a profound impact on five-year survival and recurrence in head and neck cancer patients.

Read full article

CareAcross

Posted about 4 years ago

Antidepressant use and breast-cancer recurrence

No link was identified between risk of recurrence and antidepressant use in breast cancer patients taking an anti-cancer drug and an antidepressant.

Read full article

CareAcross

Posted about 4 years ago

Breast cancer: surgery linked to positive patient results

Initial breast surgery was linked to increased and durable survival rates in women with stage IV breast cancer, a new study points out.

Read full article

CareAcross

Posted about 4 years ago

Managing stress help women deal with breast cancer

Learning how to manage stress early in their breast cancer treatment helped patients live longer without the disease, a randomized trial shows.

Read full article

CareAcross

Posted about 4 years ago

Best treatment option for breast implant-associated cancer

Complete surgical excision proved to be the best treatment for breast implant-associated anaplastic large-cell lymphoma patients as it led to low recurrence rates.

Read full article

CareAcross

Posted about 4 years ago

EU gets closer to the treatment of Merkel cell carcinoma

European regulators have taken a step closer to the treatment of Merkel cell carcinoma, adopting a positive opinion for Orphan Drug designation for avelumab.

Read full article

CareAcross

Posted about 4 years ago

Gene-targeted drug against prostate cancer

Olaparib, a drug against inherited cancer mutations, was found to benefit as many as a third of patients with prostate cancer, a new study reveals.

Read full article

CareAcross

Posted about 4 years ago

Is there a connection between exercise and breast cancer risk?

Women at high-risk of breast cancer could benefit from regular physical activity, according to a new research.

Read full article

CareAcross

Posted about 4 years ago

Breast Conservation: an option for more breast cancer patients

Breast conservation therapy should be suggested as a treatment option to breast cancer patients with larger tumors, researchers reported.

Read full article

CareAcross

Posted about 4 years ago

A more convenient treatment for low-risk prostate cancer patients

A shorter radiation therapy schedule was equally beneficial as a longer treatment schedule for some men with low-risk prostate cancer.

Read full article

CareAcross

Posted over 4 years ago

Some breast cancer patients may not benefit from Herceptin

The analysis of a trial revealed that HER2-positive breast cancer patients benefited more from receiving chemotherapy alone than chemotherapy plus trastuzumab.

Read full article

CareAcross

Posted over 4 years ago

Dietary habits of cancer survivors linked to their long-term health

A new study sheds light on the dietary habits of cancer survivors pointing out the need for dietary interventions in order to prevent a variety of health problems.

Read full article

CareAcross

Posted over 4 years ago

Weight training: a key to long-term health in breast cancer survivors

Breast cancer survivors improved their physical functionality lost due to chemotherapy when participated at a six-month weight training program, a new study shows.

Read full article

CareAcross

Posted over 4 years ago

Prenatal exposure to cancer treatment: is it dangerous for the baby?

Children born to mothers affected by cancer had no significant differences in mental development compared to children from the general population.

Read full article

CareAcross

Posted over 4 years ago

Radiation therapy benefited some elderly breast cancer patients

A retrospective analysis revealed that elderly women with early stage triple negative breast cancer benefited from adjuvant radiation therapy after lumpectomy.

Read full article

CareAcross

Posted over 4 years ago

Exercise after a cancer diagnosis to extend survival

A new analysis of 70 existing studies revealed that in patients diagnosed with cancer, physical activity extended survival rates.

Read full article

CareAcross

Posted over 4 years ago

Emotions: a risk factor for postoperative pain in breast cancer

The emotional state of a breast cancer patient who undergoes surgical intervention is found to be a risk factor for acute postoperative pain, a new study reveals.

Read full article

CareAcross

Posted over 4 years ago

Acupuncture helps breast cancer patients control hot flashes

Acupuncture may offer relief for breast cancer patients against hot flashes, particular common when taking estrogen-taking therapies, according to a new study.

Read full article

CareAcross

Posted over 4 years ago

Fertility concerns keep breast cancer patients away from treatment

Young women with breast cancer may refuse to be treated with the effective treatment, tamoxifen, due to the drug’s side effects on fertility.

Read full article

CareAcross

Posted over 4 years ago

An intervention helps women with breast cancer lose weight

Breast cancer patients often face difficulties in losing weight after treatment. Researchers now report that these women can lose weight with a personalized intervention.

Read full article

CareAcross

Posted over 4 years ago

Drinking coffee daily may lower colon cancer recurrence

Coffee’s caffeine may help colon cancer patients keep the cancer away for longer, according to a new, large study.

Read full article

CareAcross

Posted over 4 years ago

Medication adherence in breast cancer: why do patients skip drugs?

The side effects of hormone therapy as well as a poor doctor-patient communication may make breast cancer patients to intentionally or unintentionally miss a dose.

Read full article

CareAcross

Posted over 4 years ago

Chemotherapy: ineffective for older breast cancer patients

Chemotherapy proved to be inefficient for breast cancer patients over the age of 70, a new study reveals.

Read full article

CareAcross

Posted over 4 years ago

Breast cancer: Better patient outcomes with current treatments

Two currently available treatments, aromatase inhibitors and bisphosphonates benefited substantially breast cancer patients.

Read full article

CareAcross

Posted over 4 years ago

Understanding the link between cancer and metabolism

Given the absence of scientific evidence relating cancer and food, experts have created four articles describing cancer and obesity, antioxidants and biomarkers.

Read full article

CareAcross

Posted over 4 years ago

Radiation therapy: a treatment option for some breast cancer patients

A 14-year study reports that additional radiation, although it did not increase overall survival, benefited breast cancer patients as it reduced cancer recurrence.

Read full article

CareAcross

Posted over 4 years ago

Chemotherapy linked to weight gain in breast cancer survivors

Chemotherapy may lead to weight gain in breast cancer survivors with a family history of the disease, a new prospective study suggests.

Read full article

CareAcross

Posted over 4 years ago

Drug combination shows promise in metastatic breast cancer

Combining lapatinib and trastuzumab led to positive outcomes in metastatic breast cancer patients as it proved to be active and well-tolerated.

Read full article

CareAcross

Posted over 4 years ago

Better patient outcomes with new breast cancer treatment

Breast cancer patients treated with a one-week partial breast irradiation saw no increase in cancer recurrence or difference in cosmetic outcomes compared to women who received standard treatment.

Read full article

CareAcross

Posted over 4 years ago

Cryopreservation boosts fertility hopes to breast cancer patients

Breast cancer patients were able to conceive after treatment using embryo cryopreservation after ovarian stimulation, according to a new study.

Read full article

CareAcross

Posted over 4 years ago

Cancer survival may depend on sleep duration and quality

Several sleep attributes, such as sleep duration and snoring, may affect survival on breast cancer patients, a new study suggests.

Read full article

CareAcross

Posted over 4 years ago

Palbociclib: a new treatment option for metastatic breast cancer

Women with endocrine-resistant metastatic breast cancer managed to keep cancer away longer when treated with the novel drug, palbociclib, a new study shows.

Read full article

CareAcross

Posted over 4 years ago

Weight control: a possible routine part of breast cancer treatment

Female breast cancer survivors were able to lose weight through modest lifestyle changes tackling obesity, a major risk factor for breast cancer, a new study reveals.

Read full article

CareAcross

Posted over 4 years ago

Fewer side effects for esophageal cancer patients with proton therapy

New research has shown that when patients with esophageal cancer are treated with proton therapy, a new type of treatment, they experience fewer side effects.

Read full article

CareAcross

Posted over 4 years ago

Less invasive mastectomy: a safe option for breast cancer patients

A newer form of a less invasive mastectomy technique was found to be safe and equally beneficial for breast cancer patients compared to more invasive techniques.

Read full article

CareAcross

Posted over 4 years ago

Gastrointestinal tumors associated with higher cancer risk

Patients with gastrointestinal stromal tumors may develop additional malignancies before and after their diagnosis, according to the first population-based study.

Read full article

CareAcross

Posted over 4 years ago

Exercise helps women with breast cancer better tolerate chemotherapy

Breast cancer patients who follow an exercise program during chemotherapy experience less fatigue, nausea and pain - and need fewer adjustments to their dosage.

Read full article

CareAcross

Posted over 4 years ago

New guidelines: less invasive surgery for inflammatory breast cancer

According to the latest guidelines, women with inflammatory breast cancer (a rare type of breast cancer) should be offered less invasive surgery if appropriate.

Read full article

CareAcross

Posted over 4 years ago

Women with BRCA-positive breast cancer benefit from ovary removal

A review of 700 BRCA-positive breast cancer cases showed that removing ovaries significantly reduces the risk of death, especially for BRCA1 (62% lower).

Read full article

CareAcross

Posted over 4 years ago

Daily aspirin may help prevent gastrointestinal cancers

Taking aspirin regularly and for a long time may decrease the risk of gastrointestinal cancer. However, the potential risks of prolonged aspirin use should be considered.

Read full article

CareAcross

Posted almost 5 years ago

Drug trial brings promise to advanced breast cancer patients

Palbociclib, which has been approved by the US FDA for advanced breast cancer, was shown to help patients who have already received treatment for their condition.

Read full article

CareAcross

Posted almost 5 years ago

Platinum combination therapy gives hope to breast cancer patients

A new phase 2 study shows that the preoperative combination of gemcitabine, carboplatin, and iniparib is well tolerated in breast cancer patients.

Read full article

CareAcross

Posted almost 5 years ago

Combination treatment against resistance to breast cancer therapy

Researchers detailed the surprising ways in which breast cancer builds resistance to the drug lapatinib, and how to prevent it.

Read full article

CareAcross

Posted almost 5 years ago

Breast cancer screening method detects 90% of all cancers

The majority of all breast cancers can be diagnosed using magnetic resonance imaging (MRI), researchers report.

Read full article

CareAcross

Posted almost 5 years ago

A familial connection between breast and prostate cancer

Having first-degree relatives with a history of prostate cancer increases a woman’s risk of developing breast cancer, according to a new study.

Read full article

CareAcross

Posted almost 5 years ago

Breast cancer survivors may be at risk of thyroid cancer

Breast cancer survivors found to be prone to thyroid cancer, especially within five years of their breast cancer diagnosis according to a new comparative analysis.

Read full article

CareAcross

Posted almost 5 years ago

Good news for breast cancer patients who want to get pregnant

Women with breast cancer who receive goserelin had higher pregnancy rates 2 years after treatment, a study shows.

Read full article

CareAcross

Posted almost 5 years ago

New treatment for cervical cancer recommended in Europe

Bevacizumab (Avastin) has been recommended as a treatment for cervical cancer patients, expanding its current marketing authorization.

Read full article

CareAcross

Posted almost 5 years ago

Breast cancer: avoid mastectomy with pre-surgery chemotherapy

Women with breast cancer may avoid surgical removal of the breast if they undergo chemotherapy before a cancer operation.

Read full article

CareAcross

Posted almost 5 years ago

New drug helps against hormone-resistant breast cancer

A trial showed that an investigational medication for breast cancer improved progression free survival in patients with Hormone-Resistant positive (HR+) tumors.

Read full article

CareAcross

Posted almost 5 years ago

Common menopause treatment increases ovarian cancer risk

Women who take hormone replacement therapy for menopause (even for a few years) may face an increased risk of ovarian cancer, according to a detailed analysis.

Read full article

CareAcross

Posted almost 5 years ago

Novel treatment approved for metastatic breast cancer

The FDA approved Palbociclib for the treatment of postmenopausal women with advanced breast cancer that is hormone receptor-positive.

Read full article

CareAcross

Posted almost 5 years ago

New tool helps women with breast cancer avoid surgery

Ultrasound was found to be an effective tool in determining which breast cancer patients really need to proceed with surgical removal of lymph nodes.

Read full article

CareAcross

Posted almost 5 years ago

Radiotherapy may be unnecessary for some breast cancer patients

Some older women with breast cancer may avoid radiotherapy, without harming their chances of survival, a study has shown.

Read full article

CareAcross

Posted almost 5 years ago

New effective treatment in metastatic breast cancer?

Increased overall survival in women with breast cancer who received Eribulin, a chemotherapeutic agent, as a first and second line chemotherapy regimen.

Read full article

CareAcross

Posted about 5 years ago

Triple-negative breast cancer: the answer is in the genes

A gene, identified to be overactive in triple-negative breast cancer, raises hopes for new targeted treatments in this aggressive difficult-to-treat cancer subtype.

Read full article

CareAcross

Posted almost 5 years ago

Combined therapy may help women with breast cancer live longer

Almost all women with HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug were cancer-free after 3 years.

Read full article

CareAcross

Posted about 5 years ago

Eat properly and your breast cancer may never come back

Researchers found that providing nutrition education to breast cancer patients may help them prevent reoccurrence of the disease.

Read full article

CareAcross

Posted about 5 years ago

Positive results for Herceptin in HER2-positive breast cancer patients

Herceptin, when combined with chemotherapy, improves significantly long-term survival of patients with HER-2 positive breast cancer.

Read full article

CareAcross

Posted about 5 years ago

Adding agents to standard treatment helps breast cancer patients

Adding Carboplatin or bevacizumab to standard chemotherapy treatment increased the proportion of breast cancer with no residual cancer detected at surgery.

Read full article

CareAcross

Posted about 5 years ago

New promising drug in Hormone-Receptor positive breast cancer

A new study on experimental drug, Palbociclib, gives hope to women with advanced breast cancer as it doubled progression-free survival in patients.

Read full article

CareAcross

Posted about 5 years ago

Lower dietary fat linked with improved breast cancer outcomes

Among patients with early stage breast cancer who reduced their dietary fat intake, death rates were much lower for those who had hormone-unrelated disease.

Read full article

CareAcross

Posted about 5 years ago

Metastatic breast cancer patients benefit from combination treatment

Women with metastatic breast cancer benefited from a treatment combining eribulin and capecitabine in a clinical trial, as presented in the latest conference.

Read full article

CareAcross

Posted about 5 years ago

Preventing recurrence in young breast cancer patients

Breast cancer patients who retained ovarian function after chemotherapy benefited by ovarian suppression, either with tamoxifen or with aromatase inhibitor.

Read full article

CareAcross

Posted about 5 years ago

Early stage breast cancer patients under radiation therapy for too long

2/3 of early stage breast cancer patients receive longer radiation therapy than necessary after surgery (3-4 weeks longer than in the guidelines), in the USA.

Read full article

CareAcross

Posted about 5 years ago

Triple negative breast cancer patients should get genetic testing

A study found that most triple-negative breast cancer patients should undergo genetic screening to evaluate recurrence risk, and risk to other family members.

Read full article

CareAcross

Posted about 5 years ago

Half a million cancer cases per year due to being overweight or obese

A new study shows that nearly 500,000 new cancer cases per year can be attributed to "high body mass index" (BMI, a metric of weight compared to height).

Read full article

CareAcross

Posted about 5 years ago

Gene mutations found to increase risk of second breast cancer

Women who have had a tumor in one breast, and who have genetic risk for breast cancer, are at higher than average risk to develop a tumor in the other.

Read full article

CareAcross

Posted about 5 years ago

Breast cancer risk reduced by staying active and fit

New research shows: Postmenopausal women may have 20% less risk of breast cancer if they exercise vigorously. Women with the most body fat had 55% higher risk.

Read full article

CareAcross

Posted about 5 years ago

Chest radiation for Wilms tumor increases breast cancer risk

A study shows that when a child receives chest radiation for Wilms tumor (a rare childhood cancer), it faces an increased risk of breast cancer later in life.

Read full article

CareAcross

Posted about 5 years ago

Breast cancer risk predicted more efficiently by genomic sequencing

A new study shows that genomic sequencing can help women identify and manage their genetic risk for breast cancer better than what previously estimated.

Read full article

CareAcross

Posted over 5 years ago

A targeted treatment could stop endometrial tumors from growing

A drug which targets a key gene mutation could stop an aggressive endometrial (or uterine or womb) cancer and shrink tumors, according to the latest research.

Read full article

CareAcross

Posted about 5 years ago

More breast cancer patients choose reconstruction after mastectomy

New data from more than 1 million women shows that more high-risk breast cancer patients are choosing breast reconstruction after mastectomy.

Read full article

CareAcross

Posted over 5 years ago

International studies: chemotherapy and radiotherapy safe for babies

Children exposed to chemotherapy/radiotherapy while in the womb suffer no negative mental or heart-related development impacts, based on international studies.

Read full article

CareAcross

Posted over 5 years ago

Remarkable benefit for HER2-positive metastatic breast cancer patients

HER2-positive metastatic breast cancer patients can benefit from the addition of an agent to standard treatment, in unprecedented results from a clinical trial.

Read full article

CareAcross

Posted over 5 years ago

Endocrine therapy in some hormone receptor positive breast cancer patients

Older HR+ breast cancer patients with small tumors may have similar benefit from radiation therapy alone, without combining it with endocrine therapy.

Read full article

CareAcross

Posted over 5 years ago

Lymphedema risk and radiotherapy in node negative breast cancer patients

According to a secondary analysis of a large trial, radiation therapy does not increase the risk of lymphedema in patients with node-negative breast cancer.

Read full article

CareAcross

Posted over 5 years ago

Saving ovaries during chemotherapy for breast cancer: mixed results

A substance added to chemotherapy for breast cancer patients had a non-significant increase in pregnancies, and resumption of menstruation, in a clinical trial.

Read full article

CareAcross

Posted over 5 years ago

Study: wearing a bra does not increase breast cancer risk

A new study showed that post-menopausal women's risk of breast cancer does not increase because of wearing a bra.

Read full article

CareAcross

Posted over 5 years ago

Breast conserving therapy may have better outcomes than mastectomy

Patients with early-stage, hormone receptor-positive (HR+) breast cancer may benefit more from breast-conserving therapy compared to mastectomy.

Read full article

CareAcross

Posted over 5 years ago

Double mastectomy and reconstruction cause more complications than single operation

Breast cancer patients undergoing double and single mastectomy with reconstruction have higher rates of implant loss, transfusion needs & longer hospital stay.

Read full article

CareAcross

Posted over 5 years ago

New, personalized treatment reduces radiation therapy duration

A new approach to treating cancer can deliver personalized radiation therapy during surgery, reducing duration of radiation after surgery & healthy tissue risk.

Read full article

CareAcross

Posted over 5 years ago

Some breast cancer patients may not benefit from 2nd mastectomy

According to a new study, women without a BRCA gene mutation with early stage breast cancer will not gain a survival benefit if they remove the healthy breast.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer recurrence in overweight women reduced by aspirin

New research across 20 years shows that regular use of aspirin can reduce recurrence of hormone-related breast cancer in overweight and obese women by half.

Read full article

CareAcross

Posted over 5 years ago

Being overweight may be linked with 10 common cancer types

A study of 5 million people showed that larger body size is linked with 10 common cancer types incl. uterine, gallbladder, kidney, cervical, thyroid & leukemia.

Read full article

CareAcross

Posted over 5 years ago

Prostate cancer screening reduces deaths by 20% in 13-year study

A European study involving over 162,000 men demonstrated the benefits of prostate cancer screenings. However, its leader mentions the risk of over-diagnosis.

Read full article

CareAcross

Posted over 5 years ago

Two new genes may be related to breast cancer: PALB2 & MEN1

Breast cancer risk increased by 5-9 times in women with mutations in the PALB2 gene, investigators reported. Increased risk is suspected for the MEN1 gene too.

Read full article

CareAcross

Posted over 5 years ago

Avastin approved for some ovarian cancer patients in Europe

European regulators approved Avastin (bevacizumab) as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy.

Read full article

CareAcross

Posted over 5 years ago

Genetic tumor testing recommended for colorectal cancer patients

Up to 25% of colorectal cancer patients in the USA have familial risk. A new guideline recommends genetic testing for all patients newly diagnosed with the disease.

Read full article

CareAcross

Posted over 5 years ago

Women over 75 can benefit from breast cancer diagnosis via mammograms

The value of mammography in older women has been discussed a lot recently. A study suggests that such earlier diagnosis can reduce advanced breast cancer cases.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer risk raised by recent use of some birth control pills

Women who recently used birth control pills with high-dose estrogen and some formulations had increased risk for breast cancer, compared to other formulations.

Read full article

CareAcross

Posted over 5 years ago

Acupuncture helps some breast cancer patients in trial

A specific form of acupuncture which uses a small electric current helped early stage breast cancer patients with joint pain induced by aromatase inhibitors.

Read full article

CareAcross

Posted over 5 years ago

HER2-positive breast cancer experimental drug improves survival in trial

Neratinib improved disease-free survival by 33% in women with early-stage HER2-positive breast cancer in a trial, after their treatment with trastuzumab.

Read full article

CareAcross

Posted over 5 years ago

Chemotherapy may affect heart function for some breast cancer patients

Breast cancer patients who are positive for the HER-2 gene may have higher risk of heart damage during chemotherapy, according to a recently published study.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer hormonal therapy in gel form has fewer side effects

Tamoxifen is a drug taken orally. Researchers say that if applied directly to the breast in gel form, it can be as effective, and produces fewer side effects.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer drug taken through the skin has fewer side effects

Delivering Endoxifen, a drug effective in prevention and treatment of breast cancer, through the skin (and not through the mouth), may reduce its side effects.

Read full article

CareAcross

Posted over 5 years ago

Prostate cancer patients with depression face more challenges

Depressed men with localized prostate cancer were more likely to be diagnosed with more aggressive disease, received less effective treatments and survived for shorter times.

Read full article

CareAcross

Posted over 5 years ago

Breast density, breast cancer and sugar: are they related?

Many studies look for any link between sugar consumption and the risk for breast cancer. Some have shown a positive correlation, but others found no link.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer and high cholesterol linked in a large study

High blood cholesterol and breast cancer were found to be associated in a study of more than 1 million patients over a 14 year time period in the UK.

Read full article

CareAcross

Posted over 5 years ago

Locally advanced or metastatic breast cancer drug approved in Europe

The European Commission has approved a drug for patients with locally advanced or metastatic breast cancer, named eribulin.

Read full article

CareAcross

Posted over 5 years ago

Single-dose breast cancer radiation treatment possible with surgery

Women with early-stage breast cancer may now receive a one-dose radiation treatment at the same time as lumpectomy surgery, instead of treatment after surgery.

Read full article

CareAcross

Posted over 5 years ago

Risk for breast, prostate and colon cancer: dominated by genetics

Researchers studied individuals who had been adopted. They discovered that the risk for breast, prostate and colorectal cancer is highly dependent on genetics.

Read full article

CareAcross

Posted over 5 years ago

3D mammograms detect more invasive cancers, reduce need for more scans

In a study of over 450,000 women, researchers found that 3-D mammography ("digital breast tomosynthesis") detects more invasive cancers and reduces call-back rates.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer diagnosis more accurate if patient risk is considered

Researchers found that if radiologists know the patient's risk profile for breast cancer when examining their mammogram will lead to more accurate diagnoses.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer screening reduces deaths by 28% in study

Inviting women to modern mammography screening may reduce deaths from breast cancer by about 28%, according to a study from Norway.

Read full article

CareAcross

Posted over 5 years ago

Sitting associated with higher risk of cancer

In a new review of past research covering 69,000 patients, sitting was associated with a higher probability of diagnosis with colon or endometrial cancer.

Read full article

CareAcross

Posted over 5 years ago

Researchers reversed resistance to tamoxifen with inexpensive drug

An inexpensive drug against malaria was shown to reverse resistance to tamoxifen (widely used for breast cancer) in research conducted in mice.

Read full article

CareAcross

Posted over 5 years ago

Higher breast cancer risk for childhood cancer survivors

According to researchers, women who have survived a childhood cancer have 4x higher breast cancer risk, even if they were not exposed to chest radiation then.

Read full article

CareAcross

Posted over 5 years ago

Procedure reduces risk of death for women with BRCA1 breast cancer

A bilateral salpingo-oophorectomy (surgical removal of ovaries and fallopian tubes) reduced the risk of death for women with BRCA1-associated breast cancer.

Read full article

CareAcross

Posted over 5 years ago

Trastuzumab remains the standard treatment against HER2 breast cancer

In the largest clinical trial for HER2-positive breast cancer, lapatinib did not add benefit to the standard trastuzumab therapy administered after surgery.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer drug may reduce early menopause & infertility risk

Research finds that adding goserelin to breast cancer chemotherapy treatment may reduce the risk of early menopause and infertility, and even improve survival.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer recurrence improved by lifestyle changes

Two new studies show that lifestyle changes like healthy eating and regular exercise can decrease biomarkers related to breast cancer recurrence and mortality.

Read full article

CareAcross

Posted over 5 years ago

7 in 10 women who have mastectomy for both breasts do not need it

About 70% of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast.

Read full article

CareAcross

Posted over 5 years ago

Can psychological intervention reduce breast cancer stress?

Breast cancer patients can benefit from a brief, 5-week psychological intervention after surgery, in dealing with the stress of the diagnosis and operation.

Read full article

CareAcross

Posted over 5 years ago

Breastfeeding & contraceptives may reduce BRCA1/2 ovarian cancer risk

New study finds that breastfeeding, taking oral contraceptives and tubal ligation may reduce ovarian cancer risk for women with BRCA1 and BRCA2 genes mutations.

Read full article

CareAcross

Posted over 5 years ago

Brain tumor treatment options may be revealed by new technology

New technology can improve imaging on glioblastoma multiforme tumors (a form of brain tumor), which may offer important treatment information and options.

Read full article

CareAcross

Posted over 5 years ago

Obese breast cancer patients may have higher risk of death

A new study associated obesity with a 34% higher risk of death in pre-menopausal women with early breast cancer susceptible to higher hormone estrogen levels.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer: 17 'high-priority' chemicals may cause the disease

Scientists have identified 17 "high-priority" chemicals that women should avoid in order to reduce risk of breast cancer, and show how to detect their presence.

Read full article

CareAcross

Posted over 5 years ago

Chemotherapy timing is key to successful cancer treatment

A research team showed that timing the delivery of chemotherapy to the aggressive tumors dramatically shrinks lung and breast tumors, in a study.

Read full article

CareAcross

Posted over 5 years ago

Advanced breast cancer patients who sleep better survive longer

A new study indicates that sleep disruption may lead to weaker immune function or impaired hormonal stress responses. The mechanism remains unclear, however.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer treatment often results in unemployment

Nearly 1 in 3 breast cancer survivors who were working when they began treatment, were unemployed 4 years later, especially if they received chemotherapy.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer risk increased by high saturated fat diets

Women who eat a lot of fat (saturated fat in particular), may be at higher risk of certain breast cancer types, as per research on this controversial topic.

Read full article

CareAcross

Posted over 5 years ago

Predicting breast cancer recurrence and treatment response

A new non-invasive blood based test can detect breast cancer recurrence and may also predict treatment outcomes. It is based on 10 breast-cancer specific genes.

Read full article

CareAcross

Posted over 5 years ago

New drug and information on triple negative breast cancer

A new compound active against triple-negative breast cancer has been developed, which offers increased scientific understanding of this very aggressive cancer.

Read full article

CareAcross

Posted over 5 years ago

Radiotherapy for breast cancer increases risk of lung cancer

The risk of developing a primary lung tumor for women who had radiotherapy for breast cancer increases with the radiation amount, according to researchers.

Read full article

CareAcross

Posted over 5 years ago

Understanding breast cancer risk and pregnancy

Researchers are beginning to understand how pregnancy can reduce breast cancer risk, by comparing genetic materials of women who had and had not given birth.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer risk not linked to fertility drugs

Women and their doctors are concerned that fertility treatments may increase possibility of breast cancer, but this was not confirmed at a large 30-year study.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer lumpectomy repetition not needed with tissue test

No repeat lumpectomy will be needed in 96% of cases, based on unique lab testing during the operation, which will enable surgeons remove all cancerous tissue.

Read full article

CareAcross

Posted over 5 years ago

Experimental breast cancer drug improves disease control

A clinical trial for a breast cancer drug nearly doubled the time before disease got worse, but impact on overall survival was not shown to be significant.

Read full article

CareAcross

Posted over 5 years ago

Invasive lobular breast carcinoma appropriate for personalized treatment

The 2nd most common breast cancer subtype is a unique disease and appears to be a good candidate for a targeted treatment approach, according to new research.

Read full article

CareAcross

Posted over 5 years ago

Chemotherapy may be more effective with natural plant compounds

Plant compounds present in carrots and parsley may be an important weapon in delivering chemotherapy treatments for cancer more effectively.

Read full article

CareAcross

Posted over 5 years ago

Organic food does not reduce risk of cancer in women

A diet based on organic food does not change the risk of cancer in women, according to a new study which tracked over 600,000 middle-aged women for a decade.

Read full article

CareAcross

Posted over 5 years ago

New formulation of non-Hodgkin Lymphoma drug approved

European regulators have approved a subcutaneous form of MabThera for non-Hodgkin Lymphoma. This reduces patient treatment time from 2.5 hours to 5 minutes.

Read full article

CareAcross

Posted over 5 years ago

BRCA1 mutation carriers may have alternative to surgery

Women at high risk of breast and ovarian cancer due to BRCA1 mutation may be able to use already available drugs instead of undergoing irreversible surgery.

Read full article

CareAcross

Posted over 5 years ago

Targeted treatment offers hope for resistant gynecologic cancers

Women with a BRCA mutation, with gynecologic cancers which did not respond to other treatments, had improved outcomes & minimal side effects from an oral drug.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer outcomes negatively affected by obesity & diabetes

Obesity & diabetes negatively affect outcomes in breast cancer patients who receive chemotherapy as primary treatment before surgery (neoadjuvant chemotherapy).

Read full article

CareAcross

Posted over 5 years ago

Regular physical activity reduces breast cancer risk

According to researchers, women of any age can reduce the risk of breast cancer, by participating in physical activity every day, for an hour or more.

Read full article

CareAcross

Posted over 5 years ago

Potential lung cancer vaccine delivers promising early results

An investigational cancer vaccine (tecemotide) combined with cisplatin chemotherapy in a trial delivered promising results for stage 3 lung cancer.

Read full article

CareAcross

Posted over 5 years ago

ER+ breast cancer hormone therapy better targeted by genetics

The benefit of 10-year vs 5-year hormone therapy for ER+ breast cancer was genetically analyzed, helping identify the women who should receive longer treatment.

Read full article

CareAcross

Posted over 5 years ago

Radiotherapy after mastectomy benefits some breast cancer patients

Breast cancer patients, whose tumor has spread to just a few lymph nodes under their arm, may benefit if they have radiation therapy after mastectomy.

Read full article

CareAcross

Posted over 5 years ago

Breast reconstruction after mastectomy becoming more common

A new study by researchers from US private practices and academic medical centers shows that more women are receiving breast reconstruction after mastectomies.

Read full article

CareAcross

Posted over 5 years ago

Cancer mortality increased 4 times for diabetics taking insulin

Cancer patients who have been diabetics for 2 years, and were taking insulin at the time of diagnosis, have 4 times higher mortality 1 year after diagnosis.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer prognosis & treatment outcome predicted by new test

A new clinical test aims to predict survival but also the possible treatment failure for breast cancer patients. It could be available in two years.

Read full article

CareAcross

Posted over 5 years ago

Ovarian cancer risk correlates with weight, experts say

New research suggests that overweight or obese women are more likely to develop ovarian cancer, after a study on the Body Mass Index (BMI) of 4 million women.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer survival and vitamin D levels may be correlated

Research among more than 4,000 women showed that high levels of a vitamin D related metabolite could be correlated with 50% improved survival rates.

Read full article

CareAcross

Posted over 5 years ago

Non-melanoma skin cancer survivors at higher risk of other cancers later

Non-melanoma skin cancer survivors were found at higher risk for developing 30 other types of cancer later in their lives, especially those under 25 years old.

Read full article

CareAcross

Posted over 5 years ago

Cancer risk found lower if protein intake is reduced in middle age

A study found that a high protein diet in ages 50-65 was correlated with 4 times the risk of death from cancer, compared to people with low protein intake.

Read full article

CareAcross

Posted over 5 years ago

Low protein intake in middle-aged adults reduces cancer risk

A recent survey confirms that a low protein consumption diet reduces the risk of some diseases, including cancer, especially for middle aged adults.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer patients find relief in yoga after radiotherapy

Fatigue is a common side effect of radiation therapy. New research shows yoga helps breast cancer patients regulate stress hormones and overcome it more easily.

Read full article

CareAcross

Posted over 5 years ago

Could prostate cancer be predicted by substance found in urine?

Levels of a substance called “Bisphenol A” (BPA) in men’s urine could be a marker of prostate cancer. BPA is a common pollutant with estrogen activity.

Read full article

CareAcross

Posted over 5 years ago

Personalized treatment promising for invasive lobular carcinoma

Invasive lobular carcinoma is the second most common type of breast cancer. Latest research shows it may be a good candidate for personalized treatment.

Read full article

CareAcross

Posted over 5 years ago

New breast cancer surgical guidelines for better outcomes released

A comprehensive consensus guideline for breast cancer surgery has been released by major societies, aiming to improve the course of treatment and reduce costs.

Read full article

CareAcross

Posted over 5 years ago

Screening for advanced prostate cancer possible by genetics

Gene mutations in men with family history of prostate cancer can identify those at high risk. This discovery can lead to active monitoring for early detection.

Read full article

CareAcross

Posted over 5 years ago

Survival with advanced cervical cancer prolonged by bevacizumab

Combining chemotherapy with bevacizumab (also known as Avastin) extended survival in patients with advanced cervical cancer who participated in a phase 3 trial.

Read full article

CareAcross

Posted over 5 years ago

Genetic screening can identify advanced prostate cancer risk

Genetic screening of men with a family history of prostate cancer can identify those at high risk of aggressive forms of the disease, and suggest monitoring.

Read full article

CareAcross

Posted over 5 years ago

Preventive ovarian surgery for BRCA1 carriers must be done early

Women with BRCA1 mutations should have preventive ovarian surgery (“prophylactic oophorectomy”) before they turn 35. Otherwise, their risk for cancer increases. This is the outcome of a large international study.

Read full article

CareAcross

Posted over 5 years ago

Experimental lung cancer drug improves survival in late-stage trial

The non-small cell lung cancer trial compared ramucirumab (designed to treat multiple tumors) combined with docetaxel, with a placebo combined with docetaxel.

Read full article

CareAcross

Posted over 5 years ago

Potential targeted treatment in triple-negative breast cancer found

Researchers identified a protein that can be targeted for treating triple-negative breast cancer, the most aggressive form of the disease. More testing is necessary before trying this assumption in a clinical trial.

Read full article

CareAcross

Posted over 5 years ago

HER2-positive metastatic breast cancer treatment approved

The US FDA has approved trastuzumab emtansine (or T-DM1) for HER2-positive metastatic breast cancer treatment following trastuzumab and taxanes chemotherapy.

Read full article

CareAcross

Posted over 5 years ago

Drug repurposing for gastrointestinal stromal tumors found possible

37 out of 89 drugs previously approved tested were promising as treatment options against gastrointestinal stromal tumors (GISTs). Further tests are necessary to validate these initial outcomes.

Read full article

CareAcross

Posted over 5 years ago

Bladder & breast cancer subtypes found genetically similar

A new discovery showed that invasive bladder cancer and some breast cancers have genetic similarities. This could lead to new therapies and diagnostic aids.

Read full article

CareAcross

Posted over 5 years ago

Do mammograms reduce breast cancer mortality? The debate continues

In a 25-year follow-up report from a Canadian screening program, annual mammography did not reduce breast cancer mortality in women ages 40-59. This sparked further an ongoing debate on the common practice and its effects.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer survival possibly predicted by gene testing

A panel of 55 genes may predict if breast cancer will become invasive. The gene panel represents tumor suppressor & genetic alterations, and will require further testing before it could be used.

Read full article

CareAcross

Posted over 5 years ago

Double mastectomy "better" for early breast cancer patients with BRCA gene mutation

According to a study, early stage breast cancer patients with the BRCA gene mutation had better prognosis with a double mastectomy (compared to single mastectomy).

Read full article

CareAcross

Posted over 5 years ago

Risk of most common breast cancer type increased by smoking

Young women smoking a pack a day for 10 years or more have 60% higher risk of developing the most common type of breast cancer, according to the latest study.

Read full article

CareAcross

Posted over 5 years ago

Genetic testing in advanced breast cancer can help identify optimal treatments

A study of the entire DNA (whole genome testing) among 400 women with advanced breast cancer may help doctors identify optimal treatments based on genetics.

Read full article

CareAcross

Posted over 5 years ago

Brachytherapy has mixed results as breast cancer treatment

Research after lumpectomy showed that older breast cancer patients were more likely to undergo mastectomy after brachytherapy, compared to radiation therapy. However, they fared better than those who did not receive any radiation.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer hormone receptors discovered may offer new treatment options

Androgen and vitamin D receptors were found as possible targets for breast cancer treatment, beyond estrogens which are the focus of current such treatments.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer drug shows promise in mid-stage trial

An experimental breast cancer drug by Pfizer significantly delayed progression of symptoms in a mid-stage trial, as tested in post-menopausal women with locally advanced or newly diagnosed disease that had spared to other parts of the body.

Read full article

CareAcross

Posted over 5 years ago

Triple negative breast cancer cells effectively targeted in labs

New hope for a potential cure for triple negative breast cancer came from a recent discovery of an engineered virus against these tumor cells.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer chemotherapy more effective when started within 1 month of surgery

Chemotherapy after surgery (called adjuvant chemotherapy) for breast cancer should not be delayed for more than 60 days.

Read full article

CareAcross

Posted over 5 years ago

Multiple sclerosis patients may have increased cancer risk

Multiple sclerosis patients were shown to have increased risk of developing cancer, especially breast cancer. This contradicts earlier studies and requires additional research.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer metastasis explained by stem cell properties

Breast cancer stem cells were shown to be responsible for metastasis in specific ways. This discovery may enable the use of markers towards more effective treatments.

Read full article

CareAcross

Posted over 5 years ago

Childhood leukemia linked to immune cell development

Pediatric leukemia may be related to a cellular mechanism which, instead of fighting infection, rearranges DNA and may cause cancer.

Read full article

CareAcross

Posted over 5 years ago

Personalized prostate cancer treatment goes beyond Gleason scores

Researchers shift focus to prostate tumor genomic analysis to identify the best treatment among radiation, surgery, or other therapy.

Read full article

CareAcross

Posted over 5 years ago

Cancer risk in women reduced through diet and exercise

The risk of dying from cancer was found 20% lower among postmenopausal women who followed guidance on diet, weight, physical activity, and alcohol intake.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer metastasis to the brain may be protein driven

Cancer metastasis from the breast to the brain may be due to a protein, according to new research.

Read full article

CareAcross

Posted over 5 years ago

Lung cancer prevention and screening guidelines simplified

Experts are developing tools to simplify lung cancer prevention and screening recommendations.

Read full article

CareAcross

Posted over 5 years ago

Targeting separate parts of cancer cells with different drugs may become possible

A new technique that delivers two different drugs to separate parts of the cancer cell has been developed by researchers.

Read full article

CareAcross

Posted over 5 years ago

Side effects from breast cancer drugs may be eased through "any" acupuncture

Both real and fake acupuncture treatments may help alleviate side effects of drugs commonly used to treat breast cancer. Findings may help clinicians improve care for cancer patients.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer discovery could stop metastasis

A therapy to stop a cell mechanism driving the spread of breast cancer to other body parts (metastasis) has been discovered.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer patients with young children often skip radiation therapy

Breast cancer patients with young children often skip the recommended radiation treatments, due to worries about the time involved, according to researchers.

Read full article

CareAcross

Posted over 5 years ago

Cancer strongly tied to smoking & meat consumption

An international study confirms a strong link between cancer rates, and smoking as well as eating diets high in animal products.

Read full article

CareAcross

Posted over 5 years ago

Treatment against pancreatic cancer breaks down its barriers

Pancreatic cancer tumors maintain a "protective wall" around themselves. Researchers have managed to enable the body's own immune cells to break it down through antibodies.

Read full article

CareAcross

Posted over 5 years ago

BRCA testing against breast and ovarian cancer encouraged for high-risk women

Family history of breast or ovarian cancer triggers a recommendation for women to undergo testing for mutations in the BRCA cancer susceptibility genes.

Read full article

CareAcross

Posted over 5 years ago

Is breast cancer risk lower if following a tomato diet?

Eating a diet that includes plenty of tomatoes may prove important for lowering breast cancer risk, findings from a preliminary intervention study suggested.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer risk still not understood despite Angelina Jolie's mastectomy

A new study shows that awareness of Angelina Jolie's preventive mastectomy did not increase understanding of breast cancer risk.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer surgeons report improved visualization of radiation therapy treatment area

The BioZorb™ three-dimensional surgical marker dramatically improves visualization of the treatment area for radiation planning and therapy, according to a presentation at the prestigious San Antonio Breast Cancer Symposium 2013.

Read full article

CareAcross

Posted over 5 years ago

Fatigue after breast cancer treatment in study focus

A new research study will focus on which women are at highest risk for fatigue after treatment for breast cancer, and why.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer risk and sugar uptake may be related

A leading authority on breast cancer, has shown that aerobic glycolysis (glucose metabolism in the presence of oxygen) is not the consequence of the cancerous activity of malignant cells but is itself a cancerous event.

Read full article

CareAcross

Posted over 5 years ago

Cancer death risk increases with chronic kidney disease

In a new study, chronic kidney disease has been found to increase risk of dying of cancer.

Read full article

CareAcross

Posted over 5 years ago

Surgery for ovarian cancer risk reduction finds support in research

Women carrying a fault in any of the BRCA1 or BRCA2 high-risk genes have an increased risk of dying from breast and/or ovarian cancer. Many, including Angelina Jolie, choose to undergo surgery to remove their healthy breasts, ovaries or both before the disease affects them.

Read full article

CareAcross

Posted over 5 years ago

Early stage breast cancer outcomes not improved by adding fluorouracil

Fluorouracil, a widely used chemotherapy drug, offers no benefit when added to standard treatment for early-stage, node-positive breast cancer.

Read full article

CareAcross

Posted over 5 years ago

Endocrine treatment for breast cancer finds potential support from leukemia drug

Metastatic breast cancer patients starting endocrine therapy had delayed disease progression after taking the leukemia drug dasatinib (Sprycel), however, the drug failed to affect clinical response.

Read full article

CareAcross

Posted over 5 years ago

Surgery no help in metastatic breast cancer

Breast cancer found metastatic at diagnosis had similar outcome even if the primary tumor and axillary lymph nodes were removed, two clinical trials showed.

Read full article

CareAcross

Posted over 5 years ago

Lung cancer death rates continue to fall

Statistics covering the period 1975-2010 showed death rates for lung cancer, which accounts for more than 1 in 4 cancer deaths, dropping at a faster pace than in previous years. This is likely the result of decreased cigarette smoking over many years, and is now being reflected in mortality trends.

Read full article

CareAcross

Posted over 5 years ago

Metastatic breast cancer: metabolite of tamoxifen appears promising

Aromatase inhibitor-resistant metastatic breast cancer patients showed promising results with a main metabolite of the tamoxifen drug.

Read full article

CareAcross

Posted over 5 years ago

HER2 breast cancer treatment shows resistance for specific mutations

A common mutation in HER2-positive breast cancer reduced the odds of pathologic complete response to neoadjuvant therapy by 50%, according to an analysis of 2 large clinical trials.

Read full article

CareAcross

Posted over 5 years ago

Hair loss from chemotherapy may be better prevented with new cooling cap

Hair loss due to chemotherapy can be one of the most emotionally distressing side effects. An "improved" cooling cap may prevent patients undergoing cancer treatment from losing their hair.

Read full article

CareAcross

Posted over 5 years ago

Chemotherapy combination before surgery for triple-negative breast cancer shows promise

Adding the chemotherapy drug carboplatin and/or the antibody therapy bevacizumab to standard presurgery chemotherapy resulted in more triple-negative breast cancer patients with no residual cancer detected at surgery, in a phase II clinical trial.

Read full article

CareAcross

Posted over 5 years ago

Young breast cancer patients often undergo unnecessary procedures

More than 1 in 3 younger, early stage breast cancer patients undergo unnecessary imaging procedures -including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM)- at the time of staging and diagnosis, according to new research.

Read full article

CareAcross

Posted over 5 years ago

Chemoresistant breast cancer outcomes not improved by bisphosphonate treatment

Chemoresistant breast cancer patients treated with bisphosphonate zoledronate did not benefit, according to initial results of a phase 3 clinical trial presented at the 2013 San Antonio Breast Cancer Symposium.

Read full article

CareAcross

Posted over 5 years ago

AbbVie drug in regimen against difficult type of breast cancer shows promise

Triple-negative breast cancer patients who received treatment containing an experimental AbbVie drug prior to surgery may have a significantly better response, compared to those who get a standard chemotherapy regimen, according to clinical trial data.

Read full article

CareAcross

Posted over 5 years ago

Possible new Acute Lymphoblastic Leukemia (ALL) treatments

Acute Lymphoblastic Leukemia (ALL) is especially common among children and very difficult to treat. Researchers have now discovered completely new targets for potential treatment of such blood cancers.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer cases cut by more than 50% in high risk women by taking anastrozole

Post-menopausal women at high risk of breast cancer taking the drug anastrozole for 5 years had 53% less chances of developing the disease.

Read full article

CareAcross

Posted over 5 years ago

Not all breast cancer needs radiation

Older women with low-risk breast cancer who skipped radiation therapy saw small impact on recurrence risk and no effect on survival, a randomized trial showed.

Read full article

CareAcross

Posted over 5 years ago

Nipple test not an effective breast cancer screening tool, FDA warns

Breast cancer screening by nipple fluid test is not as effective as mammography, which leads to earlier diagnosis & improves treatment odds, according to US regulators.

Read full article

CareAcross

Posted over 5 years ago

Cancer deaths rise to 8.2 million, breast cancer sharply up

Cancer deaths globally rose to 8.2 million in 2012. Breast cancer deaths increased 12%, while diagnoses were 20% compared to 2008, probably due to lifestyle changes in developing nations.

Read full article

CareAcross

Posted over 5 years ago

Subgroup of women with metastatic breast cancer improved disease progression through new drug combination

Hormone receptor-positive, HER2-negative metastatic breast cancer women had longer periods of disease stability when the drug dasatinib was added to a standard antihormone therapy, letrozole.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer survivors who exercise feel less drug-associated joint pain

Breast cancer survivors taking aromatase inhibitors experienced less joint pain if they exercised while on treatment, according to results presented at the 2013 San Antonio Breast Cancer Symposium.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer subtype benefits less from treatment due to gene mutations

HER2 and hormone receptor-positive breast cancer women benefit much less from pre-surgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more specific mutations.

Read full article

CareAcross

Posted over 5 years ago

Herceptin plus Taxol highly effective in low-risk breast cancer

Almost 99% of small, node-negative, HER2+, lower-risk breast cancer patients were cancer-free at least 3 years after taking a combination of the drugs Herceptin and Taxol, a study has found.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer patients most likely to benefit from trastuzumab if they have high levels of immune cells

HER2-positive breast cancer patients with most immune cells in their tumors benefited the most from presurgery treatment with chemotherapy and trastuzumab.

Read full article

CareAcross

Posted over 5 years ago

Avoiding radiotherapy is an option for some older patients with breast cancer

Breast cancer patients over 65 may omit radiotherapy if they receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer.

Read full article

CareAcross

Posted over 5 years ago

Study identifies highly effective treatment option for patients with HER2-positive breast cancer

For patients with HER2-positive breast cancer, combining the chemotherapy drugs docetaxel & carboplatin with the HER2-targeted therapy trastuzumab was identified as an ideal post-surgery treatment option.

Read full article

CareAcross

Posted over 5 years ago

Improved treatment for childhood cancer through groundbreaking discovery

Treatment for an aggressive childhood brain tumor (known as ETMR/ETANTR) may become more effective, based on the latest pediatric cancer research.

Read full article

CareAcross

Posted over 5 years ago

Metastatic breast cancer patients may not benefit from surgery and radiation after chemotherapy

Metastatic breast cancer patients do not benefit more if, after a response to initial chemotherapy, they are treated with radiotherapy and surgical removal of the breast tumor and nearby lymph nodes.

Read full article

CareAcross

Posted over 5 years ago

Large differences in cancer survival between European countries still remain

Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century. This is according to the latest reports covering over 50% of the adult and 77% of the childhood population of Europe.

Read full article

CareAcross

Posted over 5 years ago

Keep on exercising, researchers advise older breast cancer survivors

One year of exercise can ensure steady maintenance of bone density to help prevent fractures. To build and maintain muscle strength, it is best for older breast cancer survivors to follow an ongoing exercise program of resistance and impact training.

Read full article

CareAcross

Posted over 5 years ago

Targeted agent combinations in focus for breast cancer

Breast cancer treatment via targeted agent combinations (including Herceptin, Tykerb, Taxotere, Paraplatin, Avastin, Arimidex and Aromasin) will be in focus at an upcoming symposium.

Read full article

CareAcross

Posted over 5 years ago

Insulin sensitizers reduce risk of cancer

A new study showed that a specific type of diabetes drug can decrease cancer risk by up to 32% in female patients with type 2 diabetes.

Read full article

CareAcross

Posted over 5 years ago

AbbVie leukemia drug impresses in early-stage trial

An experimental drug for leukemia controlled or eliminated signs of the disease in more than 80% of patients who had failed to benefit from previous treatments. This is an unprecedented finding that could spur use of the medicine for other cancers.

Read full article

CareAcross

Posted over 5 years ago

Obesity, smoking might threaten implants after mastectomy

Obesity and smoking increase the risk of implant failure in women who undergo breast reconstruction soon after breast removal, according to a new study.

Read full article

CareAcross

Posted over 5 years ago

Two in three patients will be surviving by end of decade

The number of people dying from breast, prostate and bowel cancer will almost halve by 2020, new figures suggest.

Read full article

CareAcross

Posted over 5 years ago

Fewer mammograms mean more positive nodes?

The frequency of mammography may not have an impact on the size of tumors when they're discovered, but fewer screens may be associated with more lymph node positivity, researchers reported.

Read full article

CareAcross

Posted over 5 years ago

Dense breasts riskier in younger women

The increased risk of cancer for women with denser breasts may be stronger in younger women, researchers reported.

Read full article

CareAcross

Posted over 5 years ago

Molecular imaging tracer aids in creation of treatment plans for brain metastases

Advanced imaging techniques can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Imaging results could also be used to predict progression-free survival.

Read full article

CareAcross

Posted over 5 years ago

Regulatory approval for biosimilar trastuzumab for treating breast cancer in India

A biotechnology company announced today that it has received Marketing Authorization from the Drugs Controller General of India (DCGI) for its biosimilar Trastuzumab being developed jointly with Mylan, for the treatment of Her 2 metastatic breast cancer.

Read full article

CareAcross

Posted over 5 years ago

3D breast screen may cut recall rates

Advanced, digital breast tomosynthesis may reduce recall rates and increase cancer detection compared with digital mammography, researchers reported.

Read full article

CareAcross

Posted over 5 years ago

Lung cancer is costliest cancer in European Union

The total cost of cancer care across the European Union (EU) was an estimated €126 billion (US$ 171.07 billion) in 2009, with lung cancer having the highest cost, at 15% of the total.

Read full article

CareAcross

Posted over 5 years ago

Researchers turn to machines to identify breast cancer type

Researchers have created a computer algorithm that successfully predicts whether estrogen is sending signals to cancer cells to grow into tumors in the breast. By finding this hormone receptor, known as estrogen receptor positive, physicians can prescribe anti-estrogen drug therapies, improving patient outcomes.

Read full article

CareAcross

Posted over 5 years ago

Negative BRCA testing may not always imply lowered breast cancer risk

Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a study published in the Cancer Epidemiology, Biomarkers & Prevention journal.

Read full article

CareAcross

Posted over 5 years ago

Older women still getting Pap smears despite guidelines

Women who've had a hysterectomy, and most women over 65, don't need regular swabs for signs of cervical cancer - but lots of them are getting the test anyway, say U.S. researchers.

Read full article

CareAcross

Posted over 5 years ago

High-fat diet during puberty speeds up breast cancer development

New findings show that eating a high-fat diet beginning at puberty speeds up the development of breast cancer and may actually increase the risk of cancer similar to a type often found in younger adult women.

Read full article

CareAcross

Posted over 5 years ago

Internet-based intervention improves cancer-related sexual dysfunction in women

An Internet-based intervention may significantly improve both sexual function and satisfaction in women with sexual dysfunction years after treatment for breast or gynecologic cancer, according to a randomized trial reported in the November issue of the Journal of the National Comprehensive Cancer Network. Leslie R. Schover, PhD, of The University of Texas MD Anderson Cancer Center, and colleagues also found that the intervention may reduce emotional distress and improve the overall quality of life in these women after treatment.

Read full article

CareAcross

Posted over 5 years ago

Roche says Kadcyla wins European approval

Roche said its drug Kadcyla, a treatment for an aggressive form of breast cancer, had been approved in Europe following U.S. approval in February.

Read full article

CareAcross

Posted over 5 years ago

Chronic diseases hinder good cancer survival rates

For bowel cancer patients with several other diseases, the one-year survival rate is 46 percent. For those without other diseases it is 80 percent. The same disparity characterizes other major types of cancer, shows new research based on figures from the Central Denmark Region.

Read full article

CareAcross

Posted over 5 years ago

Obesity a major risk factor in developing "basal-like" breast cancer

Women who are obese face an increased risk of developing an aggressive sub-type of breast cancer known as 'basal-like', according to research conducted at the University of North Carolina.

Read full article

CareAcross

Posted over 5 years ago

Cancer, arthritis treatments could target same 'glue' molecule

Two very different diseases, rheumatoid arthritis and some cancers, share a common feature - an over-abundance of a "glue" molecule that helps cells stick together. Now, a new study suggests targeting this molecule could help treat both.

Read full article

CareAcross

Posted over 5 years ago

Low estrogen 'improves efficacy' of PARP inhibitors on womb cancer

Researchers have discovered that low hormone levels may make endometrial cancer tumors more sensitive to a class of medication called PARP inhibitors - drugs that induce cancer cell death. This is according to a study published in the journal Molecular Cancer Therapeutics.

Read full article

CareAcross

Posted over 5 years ago

Study finds new explanation for resistance to breast cancer treatment

Breast cancers that initially respond to hormone therapies such as tamoxifen eventually become resistant to treatment, and a new study finds this may be because of a mutation in the receptor present in the cancer cell to which tamoxifen binds, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

Read full article

CareAcross

Posted over 5 years ago

Concurrent therapy not necessary for breast cancer patients with HER-2, study says

Giving trastuzumab and anthracyclines at the same time is effective at treating HER-2-positive breast cancer, but there is concern that this combination can be associated with an increased risk of cardiac toxicity.

Read full article

CareAcross

Posted over 5 years ago

New solution in detecting breast-cancer related lymphedema

Viewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema -- a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.

Read full article

CareAcross

Posted over 5 years ago

“One-stop” radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer

Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures – which require women to attend daily radiotherapy sessions for weeks after surgery – for some women undergoing surgery for early breast cancer.

Read full article

CareAcross

Posted over 5 years ago

Exercise May Help Breast Cancer Survivors Battle Bone Loss

Aerobics and strength-training exercises may help reduce bone loss and the risk of fractures in breast cancer survivors, a new study suggests.

Read full article

CareAcross

Posted over 5 years ago

A variety of cancers destroyed by drug combination therapy

Results from a recent preclinical study have shown that a new drug combination therapy being developed effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.

Read full article

CareAcross

Posted over 5 years ago

NCRI 2013: Prostate cancer test can spot the difference between aggressive and slow-growing tumours

A new test may overcome one of the biggest problems in prostate cancer treatment – telling slow-growing tumours from aggressive ones – according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

Read full article

CareAcross

Posted over 5 years ago

'Master protocol' could revolutionalize trials in lung cancer, and eventually other cancers

The ambitious “Master Protocol” is a collaboration among the lung cancer research community, the National Cancer Institute, the Foundation of the National Institutes of Health, the Food and Drug Administration (FDA), Friends of Cancer Research, and industry.

Read full article

CareAcross

Posted over 5 years ago

Breast cancer 'rising in under-40s' across Europe

Cases of breast cancer in women under 40 are rising across Europe, research suggests.

Read full article

CareAcross

Posted over 5 years ago

Women with abnormal cancer screening may receive delayed care due to social barriers

Social barriers (including housing and income) cause delays in cancer screening follow-up for some women, according to a recent study.

Read full article

CareAcross

Posted over 5 years ago

ASCO highlights five cancer treatments routinely performed despite lack of evidence

The American Society of Clinical Oncology (ASCO) announced its second “Top Five” list of opportunities to improve the quality and value of cancer care. Published in the Journal of Clinical Oncology (JCO), ASCO’s second Top Five list was released as part of the Choosing Wisely® campaign, sponsored by the ABIM Foundation, to encourage conversations between physicians and patients aimed at curbing the use of certain tests and procedures that are not supported by clinical research. One of the first nine medical societies to join the Choosing Wisely campaign, ASCO issued its first Top Five list in April 2012.

Read full article

CareAcross

Posted over 5 years ago

After breast cancer surgery, patient assistance programs can help

(HealthDay News) -- Patient assistance programs make it more likely that breast cancer patients will get additional treatments after they have surgery, and receive other kinds of support, a new study finds.

Read full article

CareAcross

Posted over 5 years ago

HIV drugs may get new role in fighting cancer

A type of HIV medicine that stops the AIDS virus from entering immune system cells could in future be put to work against cancer in new combination therapies being developed by drug companies.

Read full article

CareAcross

Posted over 5 years ago

Radiation can pose bigger cancer risk for children

Infants and children can be at higher risk than adults of developing some cancers when exposed to radiation, for example from nuclear accidents, a U.N. scientific report said on Friday.

Read full article

CareAcross

Posted over 5 years ago

No link between depression and cancer risk: study

Doctors can reassure patients that being depressed does not increase one's risk of cancer, French researchers say.

Read full article

CareAcross

Posted over 5 years ago

Internet users more likely to engage in cancer-preventive behaviors

Older men and women who used the internet were more likely to participate in screening for colorectal cancer, participate in physical activities, eat healthily, and smoke less, compared with those who did not use the internet, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Read full article

CareAcross

Posted over 5 years ago

BRCA1/2 mutations may alter endometrial, ovarian function

Scientists have detected significant differences in endometrial thickness and hormone levels in women with and without BRCA1/2 mutations that may play a role in cancer susceptibility or development.

Read full article

CareAcross

Posted over 5 years ago

Scientists identify genetic errors in 12 major cancer types

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

Read full article

CareAcross

Posted over 5 years ago

New imaging technique can identify breast cancer subtypes and early treatment response

An optical imaging technique that measures metabolic activity in cancer cells can accurately differentiate breast cancer subtypes, and it can detect responses to treatment as early as two days after therapy administration, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

Read full article

CareAcross

Posted over 5 years ago

Targeted treatment plus chemotherapy could benefit women with ovarian cancer

Conventional chemotherapy could further extend life in some women with ovarian cancer when used in tandem with a new type of targeted treatment, a new international study shows.

Read full article

CareAcross

Posted over 5 years ago

Scientists break blood-brain barrier to allow cancer drugs in

Cancer Research UK scientists have found a way of delivering drugs more effectively to treat life-threatening cancers that have spread to the brain, according to research published in the Journal of the National Cancer Institute.

Read full article

CareAcross

Posted over 5 years ago

Radiation Therapy Overused in Advanced Prostate Cancer, Study Says

(HealthDay News) -- Most men given radiation to control pain from advanced prostate cancer undergo more treatments than they really need, a new study suggests.

Read full article

CareAcross

Posted over 5 years ago

ASCO and the CAP release updated guideline on HER2 testing in breast cancer

The American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) today issued a joint, updated guideline aimed at improving the accuracy and reporting of human epidermal growth factor receptor 2 (HER2) testing in patients with invasive breast cancer.

Read full article

CareAcross

Posted over 5 years ago

Angelina and breast cancer copycat surge: Doctor warns patients are requesting double mastectomies even if they don't need one

Women inspired by Angelina Jolie are demanding breast removal surgery – even if they don’t need it - a leading doctor has warned. Tests for high-risk cancer gene have risen by 67% since Jolie's operation, and double mastectomies in the UK have quadrupled since then.

Read full article

CareAcross

Posted over 5 years ago

Food toxins related to cervical and liver cancer

Food such as corn tortilla, rice, chili pepper, processed sauces, chicken breast and eggs, are related with cervical and liver cancer in humans, according to scientists.

Read full article

CareAcross

Posted over 5 years ago

ECC 2013: Survival after cancer diagnosis in Europe strongly associated with government health care expenditure

The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research presented to the 2013 European Cancer Congress (ECC2013) and published simultaneously in Annals of Oncology.

Read full article

CareAcross

Posted over 5 years ago

Large Retrospective Study Finds Association Between Marriage and Cancer Outcomes

Research shows that cancer patients who were married at the time of diagnosis live markedly longer compared to unmarried ones.

Read full article

CareAcross

Posted over 5 years ago

Less is more for radiotherapy in early breast cancers

Giving radiotherapy in fewer, larger treatments is at least as safe and effective at treating early breast cancer as the international standard dose, according to the 10-year follow-up results of a major Cancer Research UK trial, published in The Lancet Oncology.

Read full article

CareAcross

Posted over 5 years ago

Women with breast cancer may overestimate secondary risks

Young women with breast cancer often overestimate both their chance of developing cancer in the other breast and how much removal of that breast is likely to protect them, a new U.S. study suggests.

Read full article

CareAcross

Posted over 5 years ago

Lowering gynecologic cancer risk

There are several things women can do to lower their risk of developing certain types of cancer and improve their chances for survival if they do develop one of them, according to the Society of Gynecologic Oncology (SGO).

Read full article